Literature DB >> 26180057

Nanotechnology: Future of Oncotherapy.

Kshipra M Gharpure1, Sherry Y Wu1, Chun Li2, Gabriel Lopez-Berestein3, Anil K Sood4.   

Abstract

Recent advances in nanotechnology have established its importance in several areas including medicine. The myriad of applications in oncology range from detection and diagnosis to drug delivery and treatment. Although nanotechnology has attracted a lot of attention, the practical application of nanotechnology to clinical cancer care is still in its infancy. This review summarizes the role that nanotechnology has played in improving cancer therapy, its potential for affecting all aspects of cancer care, and the challenges that must be overcome to realize its full promise. ©2015 American Association for Cancer Research.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26180057      PMCID： PMC4505622          DOI： 10.1158/1078-0432.CCR-14-1189

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  106 in total

1.  Co-injection of a targeted, reversibly masked endosomolytic polymer dramatically improves the efficacy of cholesterol-conjugated small interfering RNAs in vivo.

Authors:  So C Wong; Jason J Klein; Holly L Hamilton; Qili Chu; Christina L Frey; Vladimir S Trubetskoy; Julia Hegge; Darren Wakefield; David B Rozema; David L Lewis
Journal:  Nucleic Acid Ther       Date:  2012-12       Impact factor: 5.486

2.  First-in-human phase I study of the liposomal RNA interference therapeutic Atu027 in patients with advanced solid tumors.

Authors:  Beate Schultheis; Dirk Strumberg; Ansgar Santel; Christiane Vank; Frank Gebhardt; Oliver Keil; Christian Lange; Klaus Giese; Jörg Kaufmann; Michael Khan; Joachim Drevs
Journal:  J Clin Oncol       Date:  2014-11-17       Impact factor: 44.544

3.  Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.

Authors:  Nuhad K Ibrahim; Neil Desai; Sewa Legha; Patrick Soon-Shiong; Richard L Theriault; Edgardo Rivera; Bita Esmaeli; Sigrid E Ring; Agop Bedikian; Gabriel N Hortobagyi; Julie A Ellerhorst
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

Review 4.  Mouse models of advanced spontaneous metastasis for experimental therapeutics.

Authors:  Giulio Francia; William Cruz-Munoz; Shan Man; Ping Xu; Robert S Kerbel
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

5.  Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis.

Authors:  Michael E Werner; Shrirang Karve; Rohit Sukumar; Natalie D Cummings; Jonathan A Copp; Ronald C Chen; Tian Zhang; Andrew Z Wang
Journal:  Biomaterials       Date:  2011-08-16       Impact factor: 12.479

6.  Induction of endoplasmic reticulum-endosome fusion for antigen cross-presentation induced by poly (γ-glutamic acid) nanoparticles.

Authors:  Yohei Mukai; Tomoyo Yoshinaga; Mai Yoshikawa; Kazuhiko Matsuo; Tomoaki Yoshikawa; Keisuke Matsuo; Kazuyuki Niki; Yasuo Yoshioka; Naoki Okada; Shinsaku Nakagawa
Journal:  J Immunol       Date:  2011-11-16       Impact factor: 5.422

7.  Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.

Authors:  Wei Gao; Bai Xiang; Ting-Ting Meng; Feng Liu; Xian-Rong Qi
Journal:  Biomaterials       Date:  2013-03-01       Impact factor: 12.479

8.  Self-assembly synthesis, tumor cell targeting, and photothermal capabilities of antibody-coated indocyanine green nanocapsules.

Authors:  Jie Yu; David Javier; Mohammad A Yaseen; Nitin Nitin; Rebecca Richards-Kortum; Bahman Anvari; Michael S Wong
Journal:  J Am Chem Soc       Date:  2010-02-17       Impact factor: 15.419

9.  Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.

Authors:  M E R O'Brien; N Wigler; M Inbar; R Rosso; E Grischke; A Santoro; R Catane; D G Kieback; P Tomczak; S P Ackland; F Orlandi; L Mellars; L Alland; C Tendler
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

10.  Photothermal nanodrugs: potential of TNF-gold nanospheres for cancer theranostics.

Authors:  Jingwei Shao; Robert J Griffin; Ekaterina I Galanzha; Jin-Woo Kim; Nathan Koonce; Jessica Webber; Thikra Mustafa; Alexandru S Biris; Dmitry A Nedosekin; Vladimir P Zharov
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379
View more
  20 in total

Review 1.  A review of solute encapsulating nanoparticles used as delivery systems with emphasis on branched amphipathic peptide capsules.

Authors:  Sheila M Barros; Susan K Whitaker; Pinakin Sukthankar; L Adriana Avila; Sushanth Gudlur; Matt Warner; Eduardo I C Beltrão; John M Tomich
Journal:  Arch Biochem Biophys       Date:  2016-02-27       Impact factor: 4.013

2.  Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer.

Authors:  Charles J Bowerman; James D Byrne; Kevin S Chu; Allison N Schorzman; Amanda W Keeler; Candice A Sherwood; Jillian L Perry; James C Luft; David B Darr; Allison M Deal; Mary E Napier; William C Zamboni; Norman E Sharpless; Charles M Perou; Joseph M DeSimone
Journal:  Nano Lett       Date:  2016-12-22       Impact factor: 11.189

3.  Multimodality labeling strategies for the investigation of nanocrystalline cellulose biodistribution in a mouse model of breast cancer.

Authors:  Mirkka Sarparanta; Jacob Pourat; Kathryn E Carnazza; Jun Tang; Navid Paknejad; Thomas Reiner; Mauri A Kostiainen; Jason S Lewis
Journal:  Nucl Med Biol       Date:  2019-11-09       Impact factor: 2.408

Review 4.  Polyphenols delivery by polymeric materials: challenges in cancer treatment.

Authors:  Orazio Vittorio; Manuela Curcio; Monica Cojoc; Gerardo F Goya; Silke Hampel; Francesca Iemma; Anna Dubrovska; Giuseppe Cirillo
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 5.  Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment.

Authors:  Tsz-Lun Yeung; Cecilia S Leung; Fuhai Li; Stephen S T Wong; Samuel C Mok
Journal:  Biomolecules       Date:  2016-01-06

6.  Design, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors.

Authors:  Rolf F Barth; Gong Wu; W Hans Meisen; Robin J Nakkula; Weilian Yang; Tianyao Huo; David A Kellough; Pravin Kaumaya; Claudia Turro; Lawrence M Agius; Balveen Kaur
Journal:  Onco Targets Ther       Date:  2016-05-10       Impact factor: 4.147

7.  Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells.

Authors:  Myung Soo Kim; Matthew J Haney; Yuling Zhao; Vivek Mahajan; Irina Deygen; Natalia L Klyachko; Eli Inskoe; Aleksandr Piroyan; Marina Sokolsky; Onyi Okolie; Shawn D Hingtgen; Alexander V Kabanov; Elena V Batrakova
Journal:  Nanomedicine       Date:  2015-11-14       Impact factor: 5.307

Review 8.  Advances in the use of nanocarriers for cancer diagnosis and treatment.

Authors:  Débora Braga Vieira; Lionel Fernel Gamarra
Journal:  Einstein (Sao Paulo)       Date:  2016 Jan-Mar

Review 9.  Stromal Targets for Fluorescent-Guided Oncologic Surgery.

Authors:  Martin C Boonstra; Jai Prakash; Cornelis J H Van De Velde; Wilma E Mesker; Peter J K Kuppen; Alexander L Vahrmeijer; Cornelis F M Sier
Journal:  Front Oncol       Date:  2015-11-20       Impact factor: 6.244

10.  Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer.

Authors:  Wen-Ting Zhu; Sheng-Yao Liu; Lei Wu; Hua-Li Xu; Jun Wang; Guo-Xin Ni; Qing-Bing Zeng
Journal:  Int J Nanomedicine       Date:  2017-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.